OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Stephen R. Miller has been named Senior Vice President and General Manager, Patient Testing. Mr. Miller brings over 22 years of experience in the diagnostics and biotechnology industries to Transgenomic, with a proven track record of commercializing molecular diagnostic tests on a global basis.
Help employers find you! Check out all the jobs and post your resume.
